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§Seconda Universita` di Napoli, Caserta, Italy; and {Division of Molecular Biosciences, Imperial College London, United KingdomABSTRACT Resuscitation of Mtb is crucial to the etiology of Tuberculosis, because latent tuberculosis is estimated to affect
one-third of the world population. The resuscitation-promoting factor RpfB is mainly responsible for Mtb resuscitation from
dormancy. Given the impact of latent Tuberculosis, RpfB represents an interesting target for tuberculosis drug discovery. How-
ever, no molecular models of substrate binding and catalysis are hitherto available for this enzyme. Here, we identified key
interactions involved in substrate binding to RpfB by combining x-ray diffraction studies and computational approaches. The
crystal structure of RpfB catalytic domain in complex with N,N0,N00-triacetyl-chitotriose, as described here, provides the first,
to our knowledge, atomic representation of ligand recognition by RpfB and demonstrates that the strongest interactions are
established by the N-acetylglucosamine moiety in the central region of the enzyme binding cleft. Molecular dynamics analyses
provided information on the dynamic behavior of protein-substrate interactions and on the role played by the solvent in RpfB
function. These data combined with sequence conservation analysis suggest that Glu-292 is the sole residue crucial for catal-
ysis, implying that RpfB acts via the formation of an oxocarbenium ion rather than a covalent intermediate. Present data repre-
sent a solid base for the design of effective drug inhibitors of RpfB. Moreover, homology models were generated for the catalytic
domains of all members of the Mtb Rpf family (RpfA-E). The analysis of these models unveiled analogies and differences among
the different members of the Rpf protein family.INTRODUCTIONTuberculosis (TB) is the world’s leading cause of death due
to a single infectious agent, Mtb, with ~2 million deaths and
10 million new cases per year. Current treatment of TB is
not effective against multidrug-resistant, extensively drug-
resistant, and totally drug-resistant strains, not responding
to any standard treatment (1–3). Therefore, the development
of novel pharmacological regimens having a significant
impact on shortening the treatment of both drug-sensitive
and drug-resistant TB patients is urgently required.
Currently, one-third of the world’s population is estimated
to be infected with the tubercle bacillus, the majority of
which develop latent tuberculosis (4). Latently infected
individuals do not display any signs of active TB. However,
they have a finite risk of developing a clinically active
disease; this risk is markedly increased in the presence of
HIV coinfection (5). During dormancy, bacteria undergo a
reversible state of low metabolic activity in which cells
can persist for extended periods without division (6–9). Of
importance, dormant mycobacteria show a low susceptibil-
ity to antibiotics; this makes the development of active com-
pounds against latent TB an urgent task. As highlighted by
the World Health Organization Global Plan to Stop TB
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A key enzyme in Mtb resuscitation from dormancy is the
resuscitation-promoting factor RpfB, one of the five Rpf
encoded in Mtb genome (10,11). RpfB is the largest and
most complex of the five Rpf proteins encoded by Mtb
and the sole to produce delayed reactivation from chronic
tuberculosis (12). This enzyme acts by hydrolyzing the
major constituent of Mtb cell wall, peptidoglycan (PGN),
which is formed by glycan chains of b (1–4)-linked N-acetyl
glucosamine (NAG) and N-acetyl muramic acid, cross-
linked by short peptide stems. In Mtb, these peptide stems
are called DAP-type, as they contain meso-diaminopimelic
acid (DAP) residues (13–15). Although structural features
of a major portion of RpfB have been described (13), infor-
mation on key interactions of RpfB with its substrate and
key residues for catalysis is still lacking.
Despite a low sequence identity, RpfB catalytic domain
exhibits structural similarity to lysozyme, an enzyme whose
mechanism has been long debated (16–18). In hen egg white
lysozyme (HEWL), two residues have been found to be crit-
ical to the enzyme activity, Glu-35 and Asp-52. Glu-35 acts
as a proton donor to the glycosidic bond, cleaving the C-O
bond in the substrate, whereas Asp-52 acts as a nucleophile
to generate either ionic intermediate (16) or a covalent inter-
mediate (17,18). In a second step, a water molecule is
responsible for attacking either the glycosyl-enzyme inter-
mediate (17,18) or the ionic intermediate (16). The role of
the glutamic acid as a proton donor (Glu-292 in RpfB) is
shared by all proposed mechanisms of action of lysozyme,http://dx.doi.org/10.1016/j.bpj.2013.04.040
Protein-Carbohydrate Interactions in RpfB 2531whereas the type of intermediate formed and the following
water addition step is still debated and likely depends on
the lysozyme family.
Because no clues on RpfB catalytic mechanism are
hitherto available, we have combined x-ray crystallography
with molecular modeling and dynamics to obtain informa-
tion on the interaction mode of this enzyme with its sub-
strate. Here, we determined the structure of the complex
of RpfB catalytic domain and its unliganded form in com-
plex with the lysozyme inhibitor NAG3. This structure
delivers the first, to our knowledge, atomic snapshot of the
ligand recognition by RpfB. Crystallographic data were
also integrated with MD simulations to investigate the
dynamic behavior of protein-substrate interactions and to
evaluate the role of protein solvation in RpfB action. Finally,
the availability of a high resolution model for RpfB catalytic
domain provided the opportunity to generate three-dimen-
sional (3D)-models for the catalytic domains of the four
Mtb homologs of RpfB, which share significant sequence
similarities. These analyses provided clues into analogies
and differences among different Mtb Rpfs.TABLE1 Data collection and refinement statistics
RpfB-NAG3 Apo RpfB
A. Data collection
Space group P21 P21
Cell parameters a, b, c (A˚); 42.45, 51.51, 66.71 42.37, 51.40, 66.66
b () 104.39 104.15
Resolution range (A˚) 30–1.33 30–1.25
N. of unique reflections 64107 74037
Average redundancy 3.5 (3.0) 5.0 (4.5)
Rmerge (%) 6.0 (31.0) 6.0 (12.6)
Completeness (%) 98.2 (99.0) 92.6 (75.5)
Mean I/s(I) 17.0 (3.0) 51.0 (11.1)
B. Refinement
Rwork/Rwork (F > 4s) 16.4 17.7
Rfree (%) 20.5 21.9
N. of residues 320 320MATERIALS AND METHODS
Cloning, expression, and purification of proteins
The primers, Rv1009F 50-CATGCCATGGGAATCGACGGAAGCATCTG
GGA-30, and Rv1009R 50AGCCGGATCCTCAGCGCGCACCCGCT-30,
containing NcoI and HindIII restriction sites, were used to amplify the
rpfB coding sequence starting at residue Ile-280 from H37Rv strain of
Mtb. The polymerase chain reaction (~260 bp) product was cloned into
expression vector pETM-11, which gives a protein with a TEV-cleavable
N-terminal poly-His tag, denominated RpfB280–362. The resulting positive
plasmid was used to transform the Escherichia coli BL21(DE3) strain.
The overnight culture was used to inculate 1 L of LB media containing
50 mg mL1 kanamycin, the protein induction was performed when the
OD600 value of 0.7 was reached, by the addition of 1 mM IPTG at 22
C.
After ~16 h the cells were harvested and the protein was isolated by soni-
cating cell pellets resuspended in 20 mL of binding buffer (5 mM imid-
azole, NaCl 300 mM, 50 mM Tris-HCl, 5% (v/v) glycerol, pH 8.0) in the
presence of a protease-inhibitor cocktail (Roche Diagnostic). The lysate
was cleared by centrifugation at 18,000 rpm, and the supernatant loaded
on a 5 mL Ni-NTA column (Pharmacia), equilibrated with binding buffer.
After washing with 10 volumes of binding buffer, a linear gradient of imid-
azole (5–300 mM) was applied to elute the protein. The fractions containing
RpfB280–362 were pooled and dialyzed against 2 L of 50 mM Tris-HCl,
150 mM NaCl, 5% (v/v) glycerol, pH 8.0 with one exchange at 4C. After
removal of His-tag using TEV protease, the cleaved protein was purified by
a second Ni-NTA affinity run. A final purification step was carried out using
a Superdex 200 16/60 (Pharmacia) (50 mM TrisHCl, 150 mM NaCl, 10%
(v/v) glycerol, pH 8.0). All purification steps were carried out at 20C.
The homogeneity of protein was tested by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE). The calculated molecular
mass by mass spectrometry is 9127 Da. Freshly concentrated protein,
8 mg/mL, was used for crystallization experiments.N. of waters 570 600
R.m.s. deviations
Bond lengths (A˚) 0.01 0.01
Bond angles () 1.5 1.6
Values in parentheses are for the highest resolution shells.Crystallization and data collection
Crystallization trials were performed at 293 K using the hanging drop vapor
diffusion method. Preliminary crystallization conditions were setup using arobot station for high throughput crystallization screening (Hamilton
STARlet NanoJet 8þ1) and commercially available sparse-matrix kits
(Crystal Screen kits I and II, Hampton Research, Index). After manual
improvement of crystallization conditions by fine-tuning the protein and
precipitant concentrations, only tiny crystals could be obtained. Optimiza-
tion of the crystallization conditions was performed manually using the
Hampton additive screen. Best crystals were obtained using a protein con-
centration of 6 mg mL1, 0,5% (w/v) PEG8000, 1 M ammonium sulfate,
0.1 M Hepes, pH 7.5, and 120 mM benzamidine (add. 74, Hampton
Research). Indeed, benzamidine significantly improved crystal morphology
and x-ray diffraction properties. Crystals of RpfBcat apo-form were
obtained after overnight retro soaking in a solution containing 1.2 M ammo-
nium sulfate, 0,1 M Hepes, pH 7.5 to remove benzamidine from the
catalytic site. To obtain crystals of complexes with NAG3, a further 3 h
soaking was performed in the same solution and in the presence of
20 mM NAG3. NAG3 was purchased from Sigma-Aldrich. Diffraction
data for Apo-RpfB and for RpfB-NAG3 complex were collected in-house
at 100 K using a Rigaku Micromax 007 HF generator producing Cu Ka
radiation and equipped with a Saturn944 charge-coupled device detector.
Cryoprotection of the crystals was achieved by a fast soaking in paraffin
oil. The data sets were scaled using the HKL2000 program package (19),
Table 1.Structure refinement
The crystal structure of RpfBcat was solved by molecular replacement using
the program Phaser and the structure of RpfBcat in complex with benzami-
dine (PDB code 4EMN) as a starting model. Crystallographic refinement
was carried out against 95% of the measured data using the ccp4i program
suite. The remaining 5% of the observed data, which were randomly
selected, was used in Rfree calculations to monitor the progress of refine-
ment. The program REFMAC was used for the refinement of the apo
form of RpfBcat and its complex with NAG3. Noncrystallographic restraints
were applied in REFMACwith medium restraints for main-chain atoms and
loose restraints for side-chain atoms. Water molecules were incorporated
into the structure in several rounds of successive refinement, using ARP/
wARP followed by REFMAC runs (20,21). The pertinent refinement details
along with the necessary statistics for the final protein model are given
in Table 1. Atomic coordinates of unliganded and NAG3-bound forms
have been deposited in the PDB with identification codes 4kl7 and 4kpm,
respectively.Biophysical Journal 104(11) 2530–2539
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MD simulations were performed both on ligand-free and on substrate-
bound forms of RpfBcat. The crystallographic structure of the ligand-free
form was used as the starting model for the former simulation. The structure
of the complex between RpfBcat and NAG3 was used to generate an
extended RpfBcat—NAG6 complex, with all six subsites of the protein satu-
rated. This latter complex was used as the starting model in the substrate-
bound simulation.
MD simulations were performed with the GROMACS package by
using the all-atom AMBER99sb force field in combination with the
TIP4P-ew explicit water model. NAG6 was parameterized by using
GLYCAM06 (22). The latter was specifically optimized for MD simula-
tions performed with the use of Ewald summation methods, and
showed extremely good agreement with experimental data over a range
of temperatures. To avoid any bias on the hydration status of the protein
derived from the MD analyses, crystallographic water molecules were
removed from the starting models. The simulations were carried out
in the NPT ensemble with periodic boundary conditions at a constant
temperature of 300 K. A rectangular box was used to accommodate the
protein/peptide, water molecules, and ions. The systems considered for
RpfBcat and RpfBcat—NAG6 included 4311 and 4706 water molecules,
respectively.Hydration analysis: solvent density map
The MD trajectories were analyzed to primary compute solvent density
maps whose maxima are assumed to be the MD hydration sites. For
each frame of the sampling, positions of water molecules are counted
in a grid of 0.5A˚ after superimposing the current protein structure
onto a reference one. To prevent sweeping effects due to backbone flex-
ibility, frames were preliminary selected based on their Ca-root mean-
square deviation (RMSD) with the reference structure. In particular,
only structures with a Ca-RMSD value lower than 1A˚ were considered.
The maps were stored in EDM format and drawn by means of curve
levels.Hydration analysis: residence time in the
hydration sites
The time autocorrelation function P(t) was adopted to retrieve the resi-
dence time of water molecules in the MD hydration sites, using a method
previously adopted to unveil the role of collagen hydration in host-pathogen
recognition (23–25). The expression is a function of the characteristic time




dðXðtÞ  Xðt þ tÞÞ; (1)
where the function delta, d(X(t),X(tþ t)), assumes values of 0 or 1 depend-
ing on whether the indexes of the partners at times t and t þ t differ or not.
The resulting function is then fitted with an exponential model.FIGURE 1 Structure and dynamics of ligand free RpfBcat (A) (2Fo-Fc)
electron density map representing RpfB catalytic site. The water site W1
and its interactions with the catalytic site of RpfB are represented. (B)
Superposition of the four molecules in the asymmetric unit of free RpfBcat.
(C) RMSF values, calculated on backbone Ca atoms in the equilibrated
region (10–100 ns) of the MD simulation of free RpfBcat. A cartoon repre-
sentation of RpfBcat is reported to show the location of flexible loops on the
domain structure.Model building of the 3D-structure of catalytic
domains of Mtb RpfB homologs
Model building was performed by using the program Modeller (http://
modbase.compbio.ucsf.edu/ModWeb20-html/help.html) (26) and the struc-
ture of the free form of RpfBcat as a template. Taking into account the high
sequence identity, standard parameters of the modeling procedure were
used. The stereochemical quality of the models was evaluated by using
the program Procheck (27).Biophysical Journal 104(11) 2530–2539RESULTS
Crystallographic structure of RpfBcat in its ligand-
free state
In all RpfB forms hitherto crystallized, the active site of the
enzyme is occupied either by inhibitors or by residues
belonging to other domains of symmetry-related copies
(13,15). Moreover, despite extensive experimental trials
using a variety of different conditions, attempts to crystal-
lize the unliganded form of RpfB catalytic domain have
been so far unsuccessful. These observations suggest that
this domain is intrinsically endowed with a remarkable flex-
ibility that may be important for catalysis. To gain detailed
structural information into the active site of the enzyme in
its ligand-free state, we designed a specific strategy based
on the crystallization of adduct of the domain with benzami-
dine (15), followed by a retro soaking procedure to remove
the ligand. This protocol preserved crystal quality, which
diffracted at very high resolution (1.25 A˚). Crystals of
RpfBcat belong to the P21 space group, with four molecules
in the asymmetric unit (Vm 1.96 A˚3/Da, solvent content
37.2%). The vast majority of the residues of the resulting
model, including those of the active site, are characterized
by well-defined electron densities (Fig. 1 A).
Protein-Carbohydrate Interactions in RpfB 2533The inspection of the maps corresponding to the active
site clearly indicates that the retro soaking was successful
and that the structure represents a ligand-free state of the
domain (Fig. 1 A). Despite the absence of the ligand, the cat-
alytic residue Glu-292 and the residues that compose the
adjacent hydrophobic pocket (Ile-288, Trp-297, Val-309,
Phe-311, Ile-337, and Trp-352) assume well-defined confor-
mations. The quality of the model also provides a detailed
description of the solvation of the active site. Indeed, a
network of water molecules linked to the RpfBcat catalytic
site has been identified. Of these, the strongest electron den-
sity and lowest B factors characterize the water site W1,
which is hydrogen bonded to the side chain of Glu-292
and to the main-chain nitrogen atoms of Val-354 and Cys-
355 (Fig. 1 A). Superposition of the four RpfBcat molecules
in the asymmetric unit shows a highly conserved structure,
with overall backbone RMSD values lower than 0.3 A˚.
However, a significant structural difference is observed in
the D chain for the loop between Gly-348 and Pro-353,
with a maximum displacement at Ala-351 (2.1 A˚) (Fig. 1 B).Dynamics of RpfBcat in its ligand-free state
To achieve a comprehensive characterization of the struc-
tural and dynamical properties of RpfBcat in a crystal-free
context, extensive MD analyses of the domain were also
carried out. In particular, an MD simulation of 100 ns was
performed using the crystallographic structure of RpfBcat
as a starting model. To assess the evolution of the RpfBcat
structure in the simulation timescale (100 ns), a number
of stereochemical parameters (gyration radius, secondarystructure, and RMSD) were monitored along the trajec-
tories. The trends of these parameters indicated that the
simulation converged in ~10 ns (data not shown). The
RMSF profile shows that RpfBcat is a compact module
that shows a significant flexibility (RMSF larger than
1.0 A˚) in loop regions (Fig. 1 C). Consistent with the crystal
structure, the loop Gly-348-Pro-353 close to the catalytic
site also displays rather high RMSF values (Fig. 1 C), indi-
cating that its flexibility is an intrinsic characteristic of
RpfBcat structure and may modulate access to the substrate.
In addition, this flexible region close to the catalytic site
may be responsible for reluctance to crystallization of free
RpfBcat.
The trajectory structures of the MD simulation were also
used for hydration analysis aimed at identifying putative
water molecules that may play a role in catalysis. The
computed solvent density derived from the trajectory struc-
tures (see Methods for details) unveils the presence of a
number of discrete peaks in the first hydration shell
(Fig. 2), whose location is in close agreement with the posi-
tion of crystallographic water molecules. The strength of
water-protein interaction was assessed by using residence
times, occupancy, and intensity of the peaks in the hydration
map (Fig. 2). As a result, we identified a small set of five
water sites with very high residence times (>10-fold the
average) and correspond to well-defined crystallographic
water molecules. Four of them likely play a structural role
as they are either totally or nearly totally buried (Fig. S1
in the Supporting Material). Surprisingly, the fifth (W1) is
solvent accessible and lines the active site pocket of the
enzyme (Fig. 1 and Fig. S1). As frequently observed forFIGURE 2 Hydration of RpfBcat studied by MD
simulations. (A) Curve level of the solvent density
map are shown in red (contour level set as two
times the bulk values), the water W1 from x-ray
structure is shown in silver. (C) Curve levels of
the solvent density map are shown by using con-
tour levels, with darkest curves set as 8 times the
bulk solvent. (B) Distribution of the residence
times in the first and second hydration layers.
The residence time of the water W1 is indicated
by an arrow. (D) Distribution of the occupancy
factors in the first and second hydration layers.
The occupancy of the water W1 is indicated by
an arrow.
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strongly anchored to the N-terminus of an RpfBcat helix
(the C-terminal one). Specifically, W1 is strongly h-bonded
to the backbone nitrogen atoms of Val-354 and Cys-355 and
to the side chain of Glu-292, an interaction that is strongly
conserved in MD simulations. These considerations sug-
gested to us that W1 may play a crucial role in the enzyme
mechanism.Crystal structure of RpfBcat in complex
with NAG3
With the aim of understanding key interactions of NAG
moieties with RpfB, we prepared crystals of RpfBcat in com-
plex with NAG3, an effective competitive inhibitor of lyso-
zyme. Crystals of the complex were generated by using
crystals of the ligand-free form (see above) that were subse-
quently soaked with the sugar. This procedure yielded high
resolution diffracting crystals for the complex (1.33 A˚).
Electron density was clearly visible only for the NAG3
molecule bound to the RpfBcat A chain of the asymmetric
unit, whose catalytic cleft displays the largest solvent expo-
sure. The electron density maps of the catalytic site of this
chain allowed for a clear definition of NAG3 structure and
its interactions with the enzyme (Fig. 3 A). Of the six poten-
tial sugar binding sites of RpfB, hypothesized by analogyFIGURE 3 Crystal structure of the complex between RpfBcat and NAG3.
(A) Omit Fo-Fc electron density map showing a NAG3 molecule in the
enzyme binding site. (B) Location of NAG3 (stick representation) in the
B, C, and D sites of RpfBcat binding cleft. RpfBcat is shown in a surface rep-
resentation. The figure shows the deep cleft that allocates the acetyl moiety
of NAG at the C site. (C) Superposition of A chains of NAG3-bound and
free RpfBcat. Proteins are drawn in Ca trace, whereas NAG3 is draws in
stick representation.
Biophysical Journal 104(11) 2530–2539with lysozyme and designated as 4 to þ2 (formerly A,
B, C, D, E, and F), NAG3 occupies sites 3, 2, and 1
(Fig. 3 B). Superposition of equivalent A chains of NAG3-
bound RpfBcat and free RpfBcat clearly shows that a confor-
mational change involves the loop between Gly-348 and
Pro-353. Consistent with the flexibility observed for the
loop Gly-348-Pro-353 in both the crystal structure of free
Rpfcat and in MD results, this loop opens up the catalytic
site upon NAG3 binding (Fig. 3 C).
Analysis of interactions of NAG3 shows that the main
anchor of the NAG3 molecule are sites 2 and 1, whereas
only a few interactions exist with site 3 (Fig. 4). Indeed,
five hydrogen bonds link the NAG moiety at the C site
with Asp-312, Thr-315, Ala-351, and Gln-347 (Fig. 4). At
site 1, NAG moiety forms both hydrogen bonds (to Glu-
292 and Gln-310), hydrophobic interactions (with the side
chain of Pro-353), and stacking interactions with the side
chain of Tyr-305. On the other hand, the NAG moiety at
the 3 site forms only hydrogen bonds to the Gln-347
side chain (Fig. 4).Dynamics of the RpfBcat – NAG6 complex
The crystal structure of RpfBcat in complex with NAG3
showed that the central NAG moiety is the key anchoring
point of the molecule, as judged both by electron densities
and the number of hydrogen-bonding interactions with
RpfBcat. NAG3 conformation was used as a template to
model a NAG6 sugar chain, which saturated all six potential
binding subsites (4 to þ2) of the enzyme. We performed
MD simulations of this model with a twofold goal: i), to
achieve a dynamic view of RpfBcat – NAG6 interactions
and ii), to evaluate the impact on molecular recognition of
all potential sites, including those (4, þ1, and þ2) not
characterized in the crystallographic study. The analysis of
the trajectory structures shows that the RMSD profile
reached a plateau value of ~1.0 A˚ in ~10 ns. Therefore, allFIGURE 4 Interactions of NAG3 with RpfBcat. Stick representation of
the NAG3-binding site in two perpendicular views (left and right). Interact-
ing residues with NAG at the A, B, and C sites are labeled.
Protein-Carbohydrate Interactions in RpfB 2535analysis was performed on the 10–100 ns interval of the
simulation. A comparison of the RMSF values of free and
NAG6-bound RpfBcat shows that fluctuations are signifi-
cantly stifled upon NAG6 binding, in particular for the
loop Gly-348-Pro-353 close to the catalytic site (Fig. S2).
Analysis of the MD trajectory evidences a set of
hydrogen-bonding interactions between NAG6 sugar chain
and RpfBcat binding cleft that remain stable throughout
the simulation (Fig. 5). These interactions mainly occur at
the 2 site and essentially involve the main-chain atoms
of Asp-312 and Ala-351 and the side chain of Thr-315.
Hydrogen-bonding interactions at the 3 site are more tran-
sient and mainly involve the side chains of Gln-347 and
Asn-319. This latter residue also forms transient interactions
with the NAG moiety at the 4 site (Fig. 5). Notably,
hydrogen-bonding interactions with the 1 and þ1 sites
mainly involve the catalytic Glu-292, which anchors both
sugars (Fig. 5). On the other hand, the NAG moiety in
the þ2 site only occasionally forms hydrogen bonds with
the side chain of Asn-303. It is worth noting that the identi-fied set of interactions, which include most of those
observed in the crystal structure with NAG3 (Fig. 4 and
Fig. S2 B), keep NAG6 tightly bound, as no sliding of the
sugar chains is observed in the MD trajectory. These inter-
actions, which underline a strong involvement of NAG
moiety at the 2 site and a marginal role of external moi-
eties in protein binding (29), are in line with the RMSF
values calculated for NAG6 and with the distribution of
4-j angles of glycosidic bonds between subsequent NAG
moieties throughout the simulation. Indeed, the lowest
RMSF are observed for NAG2 and highest for NAGþ2
(Fig. S2 C). In addition, wider distributions of 4-j dihedral
angles corresponds to glycosidic bonds involving external
sugars, compared to internal ones (Fig. S2 D). In particular,
a broader 4 distribution characterizes the torsion angle
between NAG4 and NAG3, whereas the j distribution
is broader for the torsion angles between NAGþ1 and
NAGþ2 (Fig. S2 D). In addition, analysis of RMSDs
computed on ring atoms of each NAG moiety shows that
no major distortion of the pyranose rings occurs duringFIGURE 5 Hydrogen-bonding (including stable
and transient) interactions between NAG6 and
RpfBcat in a representative structure of the equili-
brated region of MD simulation trajectory. Panels
A and B describe A–C and D–F NAG moieties,
respectively. Insets show histograms of the distri-
bution of hydrogen-bonding distances throughout
the simulation.
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of the RpfB-NAG3 complex, all acetamide moieties in the
typical trans conformation, except for the NAG group at
position 4. For this external sugar, both cis and trans con-
formations are observed in the MD trajectories, a feature
associated with the wider distribution of 4 angles character-
izing the glycosidic bond between NAG4 and NAG3
(Fig. S2 D).FIGURE 6 Modeling of RpfBcat homologs in two perpendicular views.
Homology models of RpfA, RpfC, RpfD, and RpfE are superposed to the
crystal structure of RpfB. The location of the region connecting helix 2
and helix 3 (APR in RpfB), which is deleted in RpfC, RpfD, and RpfE,
is indicated by arrows.Structure of Rpf homologs: insights from
molecular modeling
RpfB is one of the five resuscitation-promoting factors en-
coded in Mtb genome. These proteins share a rather similar
catalytic domain, which is inserted into a variety of diverse
structural contexts in the different members of the Rpf
family (Fig. S4 A). The availability of a high-resolution
model for RpfBcat provided the opportunity to generate
3D-models for the catalytic domains of the other members
of the family.
Pairwise sequence alignments indicate that the catalytic
domains share identities in the range of 54–67%, with
RpfE and RpfC, RpfA being the closest to RpfB (65% iden-
tity) (Table 2). It is worth noting that sequence similarities
of the catalytic domains do not correlate with the
complexity of the overall proteins. The multiple alignments
of these sequences indicate the occurrence of a single signif-
icant insertion/deletion region (Fig. S4 B). Indeed, residues
325–327 of RpfB, which are present in RpfA, are missing in
the three other members of the family.
Reliable models of the catalytic domains of the other Rpfs
were generated by using the program Modeler (26) and the
crystallographic structure of RpfBcat free form as a starting
model (see Materials and Methods section for further
details). The analysis of the models indicate that the four
a-helices (residues 283–294, 312–319, 332–348, and 354–
359) that constitute the major secondary structure elements
of RpfBcat are well conserved in its homologs. In addition to
these elements, RpfBcat also contains two 310 helices at the
C-terminus of helix 2 and at the N-terminus of helix 3. The
deletion of the region 325–327 in RpfC, RpfD, and RpfE
affects the local structure of the region connecting helix 2
and helix 3 (Fig. 6). This variation, however, does not pro-
duce any significant perturbation of the overall structure
of the domain (Fig. 6).TABLE 2 Sequence identities (%) of catalytic domains of the
five Mtb Rpfs (black)
Rpf A B C D E
A – 65 64 54 66
B 71 – 59 56 64
C 73 73 – 66 67
D 72 73 73 – 61
E 74 74 70 70 –
The number of residues used in each pairwise alignment is reported in gray.
Biophysical Journal 104(11) 2530–2539An intriguing feature of the RpfBcat domain is the occur-
rence of a large number of Gly residues in the region 294–
321 (nine Gly out of 28 residues). It is important to note that
these residues are essential for maintaining the structure of
the domains as six of them present positive 4 angles, which
are rarely assumed by nonglycine residues. The importance
of these residues for the Rpf domain structural integrity sug-
gests that they are a fingerprint of these domains.
The analysis of the active site of RpfBcat homologs indi-
cate that Glu-292 (RpfB sequence) is strictly conserved.
This residue adopts in all Rpf models the same conforma-
tion as in RpfBcat; this conformation also leaves room for
docking a water molecule equivalent to W1 in each Rpf
active site. Interestingly, the hydrophobic pocket of RpfBcat,
made by Ile-288, Trp-297, Val-309, Phe-311, Ile-337,
and Trp-352, is well conserved in the other Rpfs. The pres-
ervation of this pocket in all Rpfs (A–E) suggests that a
hydrophobic environment for Glu-292 is important for
the catalytic mechanism of these enzymes. Similar to
lysozymes and lytic transglycosylases, this hydrophobic
environment likely increases the pKa of Glu-292, thus
allowing this residue to engage a hydrogen-bonding interac-
tion with glycosidic oxygen of the scissile bond (30).DISCUSSION
Mtb resuscitation from dormancy is a complex mechanism,
which requires the action of cell wall lytic enzymes as well
as of STPK kinases (31). RpfB plays a fundamental role in
this process, because it is the sole of the five Rpf of
M. tuberculosis to be not dispensable for resuscitation
in vivo (12). The study of interaction modes of this key
drug target with oligosaccharides represents an important
approach for the development of inhibitors of potential ther-
apeutic interest (32,33).
The catalytic site of RpfB structurally resembles lyso-
zyme (13–15). However, different than lysozyme types, no
Protein-Carbohydrate Interactions in RpfB 2537experimental evidence is so far available for the mechanism
of action of RpfB. Here, we here report structural investiga-
tions, conducted by combining experimental and theoretical
approaches, aimed at a), elucidating the determinants of
ligand recognition by RpfBcat, and b), gaining insights
into the catalytic mechanism of this enzyme. Crystallo-
graphic studies and MD simulations carried out on the
ligand-free form of the protein provided information on
protein dynamics and hydration. These investigations high-
lighted the presence in the catalytic site of a conserved and
highly resident water molecule that mediates the interac-
tions of the side chain of the catalytic Glu-292 with the
rest of the protein. Intriguingly, this interaction maintains
Glu-292 side chain in a rigid conformation that is similar
to that adopted by this residue in the complex with its sub-
strate. Therefore, in the ligand-free enzyme, this water
molecule is able to predispose Glu-292 side chain in its
active conformation.
Crystallographic and MD simulations on the complexes
between RpfBcat and NAG3/NAG6 provided the first repre-
sentation at atomic level of the key enzyme-carbohydrate in-
teractions. The crystal structure of RpfBcat in complex with
NAG3 evidenced that the sugar moieties occupy the subsites
from 3 to 1, which establish the strongest interactions
with the substrate. MD simulation carried out on the com-
plex between RpfBcat and NAG6 extended the analysis to
the other subsites and provided a dynamical view of the
recognition process. Overall, these data indicate that most
stable interactions involved the side chain of Thr-315 and
the backbone atoms of Asp-312 and Ala-351 in the 2
site. Consistently, Thr-315 is strictly conserved in all Mtb
homologs of RpfB (Fig. S4) as well as in several RpfB
homologs from other bacteria (Fig. S5). Similarly, Ala-
351 is strictly conserved, likely because a larger residue
would hinder NAG6 binding. Sequence conservation grades
mapped onto RpfBcat molecular surface clearly show that
whereas residues belonging to subsites from 3 to þ1 sites
are conserved, a poor conservation characterizes binding
sites 4 and þ2. In the 4 site, the highest sequence con-
servation characterizes Gln-347 (Fig. S4). This is consistent
with its key contribution to binding, observed both in the
crystal structure of the NAG3 complex and in the MD
simulations with NAG6 (Fig. 5). Notably, the equivalent
conserved glutamine in the lysozyme (Gln-104) is a key
residue in oligosaccharide binding (34). Trajectory struc-
tures also provided a clear suggestion of the site of substrate
cleavage by RpfBcat, so far experimentally unknown.
Indeed, the glycosidic bond closest to Glu-292 is that
between the sugar moieties in the 1 and the þ1 site,
both involved in hydrogen-bonding interactions with Glu-
292 (Fig. 5). This finding suggests that RpfB cleaves PGN
at the glycosidic bond between sites 1 and þ1, on analogy
with c-type lysozyme (35).
The role of the glutamic acid (Glu-292 in RpfB) in catal-
ysis is shared by all mechanisms of action proposed forlysozymes. Different than HEWL, RpfB has no equivalent
of c-type lysozyme Asp-52, which acts as a nucleophile to
generate a covalent intermediate (17,18). In RpfB, only
one further acidic amino acid, Asp-312, exists in the sub-
strate binding cleft. However, this residue exists only in
RpfB and is not conserved in its Mtb homologs (Fig. S4
B). Furthermore, both in the crystal state and in MD models,
Asp-312 side chain is far from the C-l carbon of the scissible
bond between sugar moieties in the 1 and þ1 sites (~9 A˚),
too far for covalent stabilization. Altogether, these findings
suggest that Glu-292 is the sole residue to be not dispensable
for catalysis and that catalysis does not proceed through the
formation of a covalent intermediate, but likely through the
formation of an oxocarbenium ion.
We also analyzed a possible contribution of solvent
molecules to RpfB catalytic mechanism. Water molecules
play an important role in biological structure and function,
because they can mediate enzymatic catalysis either directly
by taking part in the reaction or indirectly through providing
a solvation medium for reactants, transition state, and
products (36–39). Common to all catalytic mechanisms pro-
posed for members of the lysozyme family (18,40), the
second step of lysozyme reaction involves water addition
to the accessible face of the reaction intermediate (18,35).
As mentioned previously, our hydration analysis evidenced
the existence of a water site, W1, which is a constitutive part
of the catalytic site (Fig. 1) and is conserved in both the
crystal structures of free and NAG3-bound RpfBcat and in
MD simulated models. Of importance, W1 becomes totally
buried upon substrate ligation, as suggested by MD simula-
tions of the complex between RpfBcat and NAG6 molecule
(Fig. S6). In all states of the enzyme, it plays a major role in
anchoring Glu-292 in a proper conformation for catalytic
function. Indeed, different than in HEWL lysozyme, in
which the catalytic Glu-35 is involved in hydrogen-bonding
interactions Ala-110 backbone, Glu-292 is not directly
anchored to the protein and its conformation is locked solely
via interactions mediated by the water site W1 (Fig. 1).
Furthermore, W1 is a potential candidate water site for
hydrolysis of the enzyme reaction intermediate, because it
is in the proper position to be deprotonated by Glu-292
and become the attacking hydroxyl group.
Using the structural information derived from the crystal-
lographic and MD studies, we modeled the large muropep-
tide (NAG3NAM3Ala6Glu3DAP3) in RpfB binding cleft. In
RpfBcat-NAG3 structure and in the RpfBcat-NAG6 model,
both the acetyl moiety and the OH group on the adjacent
carbon (C3) of NAG moiety at the 2 site form stable
hydrogen bonds with Thr-315 (Fig. 5). Therefore, a NAM
chain, which would carry a peptide stem attached to the
OH group, would not fit (Fig. 5). This observation implies
that NAG moieties of PGN occupy pockets 4, 2, þ1,
whereas NAM moieties occupy sites 3, 1 and þ2.
Consequent modeling of peptide stems on the NAM moi-
eties at the B, D, and F positions shows that only minimalBiophysical Journal 104(11) 2530–2539
2538 Squeglia et al.interactions exist between RpfBcat and the peptide stems
of PGN (Fig. S7). Indeed, peptide stems protrude outward
to the protein surface, in directions compatible with the
currently accepted honeycomb pattern of peptidoglycan
polymer (41).
Finally, we used the structure of RpfBcat as a scaffold to
model the catalytic domains of its four homologs in Mtb.
Whether the existence of five Rpfs (A–E) is the result of
full redundancy or not is a debated issue. Indeed, the five
Rpfs show differential expression patterns, which vary
depending upon the growth phase of the cultures, suggesting
that they may serve distinct functions at specific phases of
infection (42). Despite their different structural complexities
and domain organizations, the five Rpf homologs present the
same fold for their catalytic domains (Fig. S4 and Fig. 6).
However, significant differences exist among their electro-
static potential surfaces (Fig. S8). The highest discrepancy
is observed for the catalytic domain of RpfE, which presents
a highly basic pI and a positively charged electrostatic
potential with a sole negative patch at the catalytic site. It
is worth noting that a negatively charged catalytic site is
functional to the mechanism of action of the enzyme, as it
likely stabilizes the positively charged reaction intermedi-
ate. A more negatively charged electrostatic potential at
the catalytic site of RpfB (due to Asp-312) may be associ-
ated with a higher activity of this enzyme, but further exper-
iments are required to analyze this issue (Fig. S8). Indeed,
RpfB has been shown to rank first among the five homologs,
although this result has been ascribed both to its structural
complexity and to its ability to interact with the cell division
protein RipA (8,43). The functional impact of the distinctive
structural features of Rpf (A–E) has not been investigated,
but it is tempting to speculate that they may be associated
with modulating Rpf function, substrate specificity/selec-
tivity and/or interaction with other proteins.
In conclusion, by adopting a combined experimental-
computational approach, we provided the first, to our knowl-
edge, structural information on interactions of RpfB with
its substrate analogs. Our results confirm the role of solva-
tion for protein function and structure (24,25,44,45) and
provide a set of information that could be exploited in future
studies for the development of RpfB inhibitors of therapeu-
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